Max Healthcare Institute Ltd. (MAXHEALTH) fundamentals
Max Healthcare Institute Ltd. is a listed company in Healthcare Services, part of the Healthcare sector, listed on the NSE as MAXHEALTH (ISIN INE027H01010). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Max Healthcare Institute Ltd. does
Max Healthcare Institute Limited is an India-based integrated healthcare provider. The Company operates through a single segment, namely Medical and Healthcare Services. It provides a wide array of services, including advanced cardiac care, lung transplants, prostate laser surgery, orthopedics, oncology, neurosciences, transplants, minimal access metabolic and bariatric surgery, and other services, including obstetrics and gynecology, pediatrics and nephrology. The Company also provides outpatient services, including consultations for a range of ailments, preventive health screenings, and laboratory services, as well as radiology, imaging, and emergency services. The Company has two strategic business units (SBUs): Max Lab and Max@Home. The Company owns and operates approximately 22 healthcare facilities across the Delhi NCR, Haryana, Punjab, Uttarakhand, Maharashtra, and Uttar Pradesh. It also offers diagnostic services to patients outside its network.
Valuation and market data
| Last close | ₹835.00 |
|---|---|
| Market capitalisation | ₹81,215 crore |
| Enterprise value | ₹84,846 crore |
| P/E (TTM) | 56.30 |
| Price to book | 7.56 |
| Price to sales (TTM) | 5.39 |
| Book value per share | ₹110.49 |
| Dividend yield | 23.95% |
| Sector | Healthcare |
| Industry | Healthcare Services |
| Listed since | Fri Aug 21 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹3,176 crore | ₹924 crore | ₹717 crore | 7.37 |
| Mar 2025 | ₹3,030 crore | ₹947 crore | ₹701 crore | 7.21 |
| Mar 2024 | ₹2,613 crore | ₹865 crore | ₹687 crore | 7.07 |
| Mar 2023 | ₹2,049 crore | ₹563 crore | ₹694 crore | 7.16 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Sep 2026:
| Promoters | 23.7% |
|---|---|
| Foreign institutions (FII) | 40.5% |
| Mutual funds | 19.3% |
| Other domestic institutions | 11.8% |
| Retail and others | 4.8% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.